Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iteos Therapeutics Inc (ITOS)

Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Iteos Therapeutics Inc 321 ARSENAL STREET BLDG 312 FLOOR 3 SUITE 301 WATERTOWN MA 02472 USA

www.iteostherapeutics.com Employees: 173 P: 339-217-0162

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

iTeos Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery and development of immuno-oncology therapeutics. iTeos Therapeutics Inc. is based in Cambridge, United States.

Key Statistics

Overview:

Market Capitalization, $K 448,681
Enterprise Value, $K 306,551
Shares Outstanding, K 44,205
Float, K 37,928
% Float 85.80%
Short Volume Ratio 0.33
% of Insider Shareholders 14.20%
% of Institutional Shareholders 97.16%

Financials:

Annual Sales, $ 35,000 K
Annual Net Income, $ -134,410 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -78,730 K
EBIT, $ -221,940 K
EBITDA, $ -232,220 K

Growth:

1-Year Return -40.82%
3-Year Return -55.29%
5-Year Return -60.66%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.51 on 08/06/25
Next Earnings Date 11/11/25
Earnings Per Share ttm -4.37
EPS Growth vs. Prev Qtr -88.75%
EPS Growth vs. Prev Year -738.89%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ITOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -33.26%
Return-on-Assets % -28.16%
Profit Margin % -384.03%
Debt/Equity 0.00
Price/Sales 12.79
Price/Cash Flow N/A
Price/Book 0.79
Book Value/Share 12.90
Interest Coverage -1.45
60-Month Beta 1.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.